Industry News
Support continues for biotechnologies
Australians continue to strongly support biotechnologies that provide health and environmental benefits, but support for genetically modified (GM) foods has dropped slightly since 2007, a new survey has found.
[ + ]Insight into how immune cells cause diabetes
Researchers from Sydney's Garvan Institute of Medical Research have uncovered a mechanism by which immune cells interact, giving insight into the causes of Type 1 diabetes, where the body's own immune cells target the insulin-producing beta cells in the pancreas. [ + ]
R&D schemes set scene for NZ to boost science spend
IRL Chief Executive Shaun Coffey has applauded the introduction of the technology transfer voucher funding scheme announced recently by the government but says the country as a whole can do more.
[ + ]Hatchtech raises $6.3 million for Phase IIb head lice trial
Melbourne biotech Hatchtech announced today that it has raised $6.3 million to fund Phase IIb clinical trials for its novel treatment for head lice. [ + ]
Aussies give thumbs up to biotechnology
A national survey to gauge how Australians feel about biotechnology has shown that the majority are strongly supportive of those efforts which lead to health and environmental benefits, while support for genetically modified (GM) food has fallen amid ongoing confusion and uncertainty. [ + ]
Lab tests point to better outcome for human blood cancers
The treatment of a range of human blood cancers, such as chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia, may be improved as a result of international research involving The University of Western Australia.
[ + ]IRL granted technology transfer voucher accreditation
IRL has been selected as one of six accredited research organisations for the first phase of the government-funded technology transfer voucher funding scheme.
[ + ]Glycoproteomics collaboration
Australian Proteome Analysis Facility (APAF), Macquarie University and Agilent Technologies Australia have announced a joint research collaboration in the field of glycoproteomics, to be led by Professor Nicolle Packer.
[ + ]University of Sydney opens OSBF
The University of Sydney’s Bosch Institute opened its new core facility - the Oxidative Stress Bioanalytical Facility (OSBF) in the Medical Foundation Building.
[ + ]The nostril: a window to the brain
A new research method developed by Australian scientist Alan Mackay-Sim and his team has the potential to shed light on the biological underpinnings of mental illnesses. [ + ]
AusBiotech 2010 Biotech Profile: Starpharma
In an industry obsessed with finding the next big blockbuster, Melbourne-based Starpharma is using its technology platform to steadily accumulate wins in a broad range of markets. [ + ]
Market report: Healthcare index ends the week up as AusBiotech 2010 draws to a close
The heavy back-slapping and self-congratulations at this week’s AusBiotech 2010 shindig in Melbourne may have rubbed off a little on the S&P/ASX 200 Healthcare Index, which managed to claw back most of last week’s losses. [ + ]
Genetic clues to psoriasis revealed
European researchers have identified for the first time a number of genetic variants indicating increased risk of the skin disease psoriasis. [ + ]
Melanoma researcher wins $1 million Pfizer research fellowship
Dr Mark Shackleton was named at last night’s AusBiotech 2010 Conference Dinner as the winner of the 2011 Pfizer Australia Senior Research Fellowship grant for his proposal ‘Identifying determinants of human melanoma progression’. [ + ]
ChemGenex welcomes Cephalon as new investor
Melbourne cancer biotech ChemGenex announced today that US pharma Cephalon has become a major new investor in the company. The announcement saw the company’s shares surge almost 15 percent to $0.50 by mid afternoon trade. [ + ]
